Neutrophil‐to‐eosinophil ratio as a biomarker for clinical outcomes in advanced stage melanoma patients treated with anti‐PD‐1 therapy.
Saved in:
| Title: | Neutrophil‐to‐eosinophil ratio as a biomarker for clinical outcomes in advanced stage melanoma patients treated with anti‐PD‐1 therapy. |
|---|---|
| Authors: | Pozorski, Vincent1 (AUTHOR), Park, Yeonhee2 (AUTHOR), Mohamoud, Yusuf1 (AUTHOR), Tesfamichael, Dahlia1 (AUTHOR), Emamekhoo, Hamid3,4 (AUTHOR), Birbrair, Alexander1,5 (AUTHOR), Albertini, Mark R.3,4,5,6 (AUTHOR), Ma, Vincent T.3,4,5 (AUTHOR) vtma@medicine.wisc.edu |
| Source: | Pigment Cell & Melanoma Research. Nov2023, Vol. 36 Issue 6, p501-511. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
